LIGAND PHARMACEUTICALS INCORPORATED Investment Income, Nonoperating
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Investment Income, Nonoperating of $7.40 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNonoperating · last filed 2019-11-08
- LIGAND PHARMACEUTICALS INCORPORATED investment income, nonoperating for the quarter ending 2019-09-30 was $7.40M, a 35.11% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED investment income, nonoperating for the quarter ending 2019-06-30 was $9.29M, a 236.17% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED investment income, nonoperating for the quarter ending 2019-03-31 was $5.91M, a 575.31% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED investment income, nonoperating for the quarter ending 2018-12-31 was $4.89M, a 643.99% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED investment income, nonoperating for fiscal 2018 was $14.00M, a 579.56% increase from fiscal 2017.
- LIGAND PHARMACEUTICALS INCORPORATED investment income, nonoperating for fiscal 2017 was $2.06M, a 210.24% increase from fiscal 2016.
- LIGAND PHARMACEUTICALS INCORPORATED investment income, nonoperating for fiscal 2016 was $664.00K.
| Period end | Investment Income, Nonoperating 3 month | Investment Income, Nonoperating 6 month | Investment Income, Nonoperating 9 month | Investment Income, Nonoperating 12 month |
|---|---|---|---|---|
| 2019-09-30 | $7.40M 10-Q · filed 2019-11-08 | $16.68M derived: sum of 2 quarters · filed 2019-11-08 | $22.59M 10-Q · filed 2019-11-08 | $27.48M derived: sum of 4 quarters · filed 2019-11-08 |
| 2019-06-30 | $9.29M 10-Q · filed 2019-08-08 | $15.19M 10-Q · filed 2019-08-08 | $20.08M derived: sum of 3 quarters · filed 2019-08-08 | $25.56M derived: sum of 4 quarters · filed 2019-11-08 |
| 2019-03-31 | $5.91M 10-Q · filed 2019-05-09 | $10.80M derived: sum of 2 quarters · filed 2019-05-09 | $16.27M derived: sum of 3 quarters · filed 2019-11-08 | $19.03M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-12-31 | $4.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $10.36M derived: sum of 2 quarters · filed 2019-11-08 | $13.12M derived: sum of 3 quarters · filed 2019-11-08 | $14.00M 10-K · filed 2019-02-28 |
| 2018-09-30 | $5.47M 10-Q · filed 2019-11-08 | $8.24M derived: sum of 2 quarters · filed 2019-11-08 | $9.11M 10-Q · filed 2019-11-08 | $9.77M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $2.76M 10-Q · filed 2019-08-08 | $3.64M 10-Q · filed 2019-08-08 | $4.29M derived: sum of 3 quarters · filed 2019-08-08 | $4.86M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $875.00K 10-Q · filed 2019-05-09 | $1.53M derived: sum of 2 quarters · filed 2019-05-09 | $2.10M derived: sum of 3 quarters · filed 2019-05-09 | $2.58M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $657.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $1.22M derived: sum of 2 quarters · filed 2019-02-28 | $1.70M derived: sum of 3 quarters · filed 2019-02-28 | $2.06M 10-K · filed 2019-02-28 |
| 2017-09-30 | $564.00K 10-Q · filed 2018-11-08 | $1.04M derived: sum of 2 quarters · filed 2018-11-08 | $1.40M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $481.00K 10-Q · filed 2018-08-08 | $835.00K 10-Q · filed 2018-08-08 | ||
| 2016-12-31 | $664.00K 10-K · filed 2019-02-28 |